Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 45.
[20-40] [0 - 20][0 - 45][40-44][40-60]

Ident.	Authors (with country if any)	Title
000C12 (2010)	Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di Paolo	Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
000D51 (2010)	T. Van Eimeren ; G. Pellecchia ; R. Cilia ; B. Ballanger ; T. D. L. Steeves ; S. Houle ; J. M. Miyasaki ; M. Zurowski ; A. E. Lang ; A. P. Strafella	Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD(e–Pub ahead of print)
000D74 (2011)	Lori-Ann R. Sacrey [Canada] ; Scott G. Travis ; Ian Q. Whishaw	Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task.
000D93 (2011)	James K R. Stevenson [Canada] ; Meeko M K. Oishi ; Sara Farajian ; Edmond Cretu ; Edna Ty ; Martin J. Mckeown	Response to sensory uncertainty in Parkinson's disease: a marker of cerebellar dysfunction?
000E06 (2011)	E P Pasman [Canada] ; C D Murnaghan ; B R Bloem ; M G Carpenter	Balance problems with Parkinson's disease: are they anxiety-dependent?
000F27 (2011)	Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. Brotchie	Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?
000F94 (2012)	Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr	Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
001040 (2012)	Alain Dagher [Canada]	Addiction as aberrant learning-evidence from Parkinson's disease.
001058 (2012)	K. Martinu [Canada] ; C. Degroot ; C. Madjar ; A P Strafella ; O. Monchi	Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
001154 (2012)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie	L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001221 (2013)	Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo	MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
001227 (1990)	N R Campbell ; D. Rankine ; A E Goodridge ; B B Hasinoff ; M. Kara	Sinemet-ferrous sulphate interaction in patients with Parkinson's disease.
001287 (2013)	Vincent A. Jourdain [Canada] ; Laurent Grégoire ; Marc Morissette ; Nicolas Morin ; Martin Parent ; Thérèse Di Paolo	Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy.
001327 (2013)	Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox	Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
001354 (2013)	David Mongeon [Canada] ; Pierre Blanchet ; Julie Messier	Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
001541 (2013)	Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan ; Martin J. Mckeown ; Silke Appel-Cresswell ; A Jon Stoessl ; Jason J S. Barton	Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
001668 (2014)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]	UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
001954 (2014)	Kristina Martinu [Canada] ; Atsuko Nagano-Saito [Canada] ; Stuart Fogel [Canada] ; Oury Monchi [Canada]	Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD
001A06 (2015)	Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca Cicchetti	Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease
001A98 (2015)	Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]	Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
001C73 (2015)	Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]	Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022